Intervention not reported
Use of corticosteroids (proportion of patients using corticosteroids) · children with PFAPA
The intervention may leads to lower use of corticosteroids (proportion of patients using corticosteroids) (low certainty).
1 finding from 1 review
Intervention not reported
Absence or time off school · children with PFAPA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life · children with PFAPA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease severity as measured by patient‐reported symptom score (total nasal symptom score) · adults and children > 12 with non‐allergic rhinitis
1 finding from 1 review
Significant adverse event: epistaxis · adults and children > 12 with non‐allergic rhinitis
Intranasal corticosteroids probably leads to higher significant adverse event: epistaxis compared with placebo (moderate certainty).
1 finding from 1 review
Disease‐specific health‐related quality of life Short Form 12 (SF‐12v2) (range 0 to 800) · adults and children > 12 with non‐allergic rhinitis
1 finding from 1 review
Health outcomes Peak expiratory flow readings (higher readings indicate better peak flow) · adults and children > 12 with non‐allergic rhinitis
It is very uncertain whether intranasal corticosteroids changes objective measurement of airflow: peak flow rate (expiratory) compared with placebo (very low certainty).
1 finding from 1 review
Other adverse events · adults and children > 12 with non‐allergic rhinitis
Intranasal corticosteroids showed no clear difference in other adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Incidence rate of Frey's syndrome assessed clinically · patients undergoing parotidectomy
It is very uncertain whether sternocleidomastoid muscle flap changes incidence rate of Frey's syndrome assessed clinically compared with no flap (very low certainty).
1 finding from 1 review
Other complications As measured by: clinical methods and subjective perception · patients undergoing parotidectomy
Sternocleidomastoid muscle flap showed no clear difference in other complications As measured by: clinical methods and subjective… compared with no flap (low certainty).
1 finding from 1 review
Incidence rate of Frey's syndrome assessed by participants · patients undergoing parotidectomy
Sternocleidomastoid muscle flap showed no clear difference in incidence rate of Frey's syndrome assessed by participants compared with no flap (low certainty).
1 finding from 1 review
Incidence rate of Frey's syndrome assessed clinically · patients undergoing parotidectomy
It is very uncertain whether acellular dermal matrix changes incidence rate of Frey's syndrome assessed clinically compared with control (very low certainty).
1 finding from 1 review
Other complications As measured by clinical methods · patients undergoing parotidectomy
Acellular dermal matrix may leads to higher other complications As measured by clinical methods compared with control (low certainty).
1 finding from 1 review
Incidence rate of Frey's syndrome assessed by participants · patients undergoing parotidectomy
Acellular dermal matrix showed no clear difference in incidence rate of Frey's syndrome assessed by participants compared with control (low certainty).
1 finding from 1 review
Control of epistaxis: episodes of re‐bleeding over 10 days All treatments (topical and oral) · adults with nasal haemorrhage (epistaxis)
Tranexamic acid probably leads to lower control of epistaxis: episodes of re‐bleeding over 10 days All… compared with placebo plus usual care or usual care alone (moderate certainty).
1 finding from 1 review
Severity of re‐bleeding: proportion of patients requiring blood transfusion within 10 days · adults with nasal haemorrhage (epistaxis)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · adults with nasal haemorrhage (epistaxis)
1 finding from 1 review
no estimate extracted
10 participants
GRADE not reported
Adverse effects: serious or other · adults with nasal haemorrhage (epistaxis)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Control of epistaxis: episodes of re‐bleeding over 10 days Oral treatment only · adults with nasal haemorrhage (epistaxis)
Tranexamic acid probably leads to lower control of epistaxis: episodes of re‐bleeding over 10 days Oral… compared with placebo plus usual care or usual care alone (moderate certainty).
1 finding from 1 review
Control of epistaxis: episodes of re‐bleeding over 10 days Topical application (10% gel) only · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in control of epistaxis: episodes of re‐bleeding over 10 days Topical… compared with placebo plus usual care or usual care alone (low certainty).
1 finding from 1 review